已收盘 09-04 16:00:00 美东时间
+0.380
+1.67%
今日重点评级关注:Ascendiant Capital:维持PAVmed"买入"评级,目标价从56美元升至57美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9.25美元升至9.5美元
08-28 16:15
Cantor Fitzgerald analyst Manish A. Somaiya maintains Ameresco (NYSE:AMRC) with a Overweight and lowers the price target from $44 to $36.
08-27 18:59
经济观察网 阿梅雷斯克(AMRC)近期获多家机构更新评级,同时高管持股相关披露较为密集,内部人交易节奏受市场关注。 机构观点: 8 月 5 日多家大行集中更新评...
08-23 22:47
研发mRNA癌症疫苗获华尔街齐看好!Moderna周涨129%;AMLX周涨78%,全球首创GLP-1R拮抗剂三期临床试验成功;比特币大幅反弹突破7.8万美元!MSTR周涨28%>>
08-22 10:20
Ameresco ( ($AMRC) ) has shared an announcement. Ameresco announced on August 1...
08-20 04:28
Ameresco is pleased to reiterate its guidance for full year 2026 revenue of $2.0 billion to $2.2 billion, Adjusted EBITDA of $250 million to $270 million, and Non-GAAP EPS of $1.15 to $1.35.
08-20 04:13
今日重点评级关注:HC Wainwright & Co.:维持Tango Therapeutics"买入"评级,目标价从66美元升至68美元;康托·菲茨杰拉德:维持Duos Technologies Group"超配"评级,目标价从26美元升至27美元
08-19 08:37
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst Ben Chaiken downgraded Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) from Outperf...
08-18 20:15
Baird analyst Ben Kallo downgrades Ameresco (NYSE:AMRC) from Outperform to Neutral and lowers the price target from $36 to $32.
08-18 19:19
今日重点评级关注:HC Wainwright & Co.:维持Precigen"买入"评级,目标价从14美元升至18美元;HC Wainwright & Co.:维持Sophia Genetics"买入"评级,目标价从12美元升至14美元
08-06 11:36